Loading...
•
Mar 31, 2025
Doximity Q4 2025 Earnings Report
Doximity announced fourth quarter and fiscal year 2025 financial results.
Key Takeaways
Doximity reported strong financial results for the fourth quarter and fiscal year 2025, with significant year-over-year increases in revenue, net income, and cash flows. The company highlighted record engagement and the positive impact of its tools on medical professionals.
Q4 total revenues reached $138.3 million, a 17% increase year-over-year.
Q4 net income was $62.5 million, resulting in a 45.2% margin, up from 34.4% in the prior year.
Q4 non-GAAP net income was $77.7 million, representing a 56.2% margin.
Q4 free cash flow was strong at $97.0 million, a 56% increase year-over-year.
Forward Guidance
Doximity provided guidance for the first quarter of fiscal year 2026 and the full fiscal year 2026.
Positive Outlook
- Fiscal Q1 2026 revenue is expected to be between $139 million and $140 million.
- Fiscal Q1 2026 Adjusted EBITDA is expected to be between $71 million and $72 million.
- Fiscal Year 2026 revenue is expected to be between $619 million and $631 million.
- Fiscal Year 2026 Adjusted EBITDA is expected to be between $333 million and $345 million.
- Guidance indicates continued growth in both revenue and profitability.
Challenges Ahead
- No specific negative guidance was provided in the report.
- N/A
- N/A
- N/A
- N/A
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...